EP Patent

EP2029524B1 — Process for the production of 2- [4 - ( 3- and 2-fluorobenzyloxy) benzylamino] propan amides

Assigned to Newron Pharmaceuticals SpA · Expires 2014-11-26 · 11y expired

What this patent protects

Patent listed against safinamide-mesylate.

Drugs covered by this patent

safinamide-mesylate (SAFINAMIDE MESYLATE)

Patent Metadata

Patent number: EP2029524B1
Jurisdiction: EP
Classification: —
Expires: 2014-11-26
Drug substance claim: No
Drug product claim: No
Assignee: Newron Pharmaceuticals SpA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.